You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rotigotine

Showing 1 - 25 of 105
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Substance-Related Disorders Trial in Richmond (Rotigotine Transdermal System [Neupro], Placebo)

Not yet recruiting
  • Substance-Related Disorders
  • Rotigotine Transdermal System [Neupro]
  • Placebo
  • Richmond, Virginia
    Virginia Commonwealth University
Jun 1, 2023

Frontotemporal Dementia, Dementia, Aphasia, Primary Progressive Trial in Brescia, Rome (Rotigotine 4Mg/24Hrs Patch, Rotigotine

Active, not recruiting
  • Frontotemporal Dementia
  • +19 more
  • Rotigotine 4Mg/24Hrs Patch
  • +2 more
  • Brescia, Italy
  • +2 more
Jul 7, 2022

Parkinson Disease Trial in Hamburg (Rotigotine TTS (Test), Neupro (Reference))

Terminated
  • Parkinson Disease
  • Rotigotine TTS (Test)
  • Neupro (Reference)
  • Hamburg, Germany
    Sandoz Investigative Site
Nov 5, 2020

Parkinson Disease Trial in Salt Lake City (LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection),

Completed
  • Parkinson Disease
  • LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection)
  • Neupro 4 mg / 24 Hr. Transdermal Patch
  • Salt Lake City, Utah
    Pharmaceutical Research Associates, Inc.
Oct 13, 2020

Parkinson Disease Trial in Baltimore (LY03003, Neupro 4Mg/24Hr Transdermal Patch)

Completed
  • Parkinson Disease
  • LY03003
  • Neupro 4Mg/24Hr Transdermal Patch
  • Baltimore, Maryland
    Pharmaron CPC, Inc.
Mar 31, 2021

Parkinson's Disease Trial in Beijing (LY03003( the name of rotigotine), Placebo)

Completed
  • Parkinson's Disease
  • LY03003( the name of rotigotine)
  • Placebo
  • Beijing, China
    Peking University Third Hospital
Jul 1, 2020

Parkinson Disease Trial in Beijing (LY03003(Rotigotine,extended-release microspheres), Placebo,extended-release microspheres)

Unknown status
  • Parkinson Disease
  • LY03003(Rotigotine,extended-release microspheres)
  • Placebo,extended-release microspheres
  • Beijing, China
    Xuanwu Hospital Capital Medical University
Sep 25, 2020

Parkinson's Disease Trial in United States (SER-214)

Active, not recruiting
  • Parkinson's Disease
  • Birmingham, Alabama
  • +3 more
Oct 20, 2020

Parkinson Disease Trial in Beijing, Shenyang (LY03003 ( Rotigotine, extended-release microspheres), Placebo, extended-release

Completed
  • Parkinson Disease
  • LY03003 ( Rotigotine, extended-release microspheres)
  • Placebo, extended-release microspheres
  • Beijing, China
  • +2 more
Sep 21, 2020

Anxiety Disorders, Parkinson Disease Trial in Baltimore (rotigotine transdermal patch, )

Terminated
Has Results
  • Anxiety Disorders
  • Parkinson Disease
  • rotigotine transdermal patch
  • placebo
  • Baltimore, Maryland
    Johns Hopkins University School of Medicine
Mar 18, 2020

The Practical Effect of Neupro

Recruiting
  • Parkinson's Disease
  • Beijin, China
    Peking University Third Hospital
Jul 8, 2021

Parkinson Disease Trial (Rotigotine, extended-release microspheres, Placebo, extended-release microspheres)

Completed
  • Parkinson Disease
  • Rotigotine, extended-release microspheres
  • Placebo, extended-release microspheres
  • (no location specified)
Aug 2, 2019

Alzheimer Trial in Rome (Rotigotine transdermal patch, Placebo)

Completed
  • Alzheimer Disease
  • Rotigotine transdermal patch
  • Placebo
  • Rome, Italy
    Santa Lucia Foundation
Dec 14, 2018

Parkinson Disease Trial in Netherlands, United Kingdom, United States (RO7486967, Placebo)

Recruiting
  • Parkinson Disease
  • Birmingham, Alabama
  • +12 more
Jun 21, 2023

Brain Tumors, Epilepsy, Migraine Trial (Listed for each disorder below, up to three drugs per disorder (too many characters to

Enrolling by invitation
  • Brain Tumors
  • +9 more
  • Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description)
  • (no location specified)
Aug 9, 2021

Parkinson Disease Trial in Hallandale Beach, Atlanta (LY03003)

Completed
  • Parkinson Disease
  • Hallandale Beach, Florida
  • +1 more
Nov 6, 2018

Parkinson Disease Trial in Beijing (LY03003)

Recruiting
  • Parkinson Disease
  • Beijing, China
    Xuanwu Hospital Capital Medical University
Nov 13, 2020

Restless Legs Syndrome (RLS) Trial in Montpellier (Rotigotine, Placebo patchs)

Completed
  • Restless Legs Syndrome (RLS)
  • Rotigotine
  • Placebo patchs
  • Montpellier, France
    UH Montpellier
May 9, 2018

Parkinson Disease Trial (LY03003)

Completed
  • Parkinson Disease
  • (no location specified)
Nov 11, 2020

Parkinson´s Disease Trial in United States (Kinesia-ONE™, Kinesia-360™, Rotigotine)

Completed
Has Results
  • Parkinson´s Disease
  • Kinesia-ONE™
  • +2 more
  • Fountain Valley, California
  • +7 more
Feb 16, 2019

Idiopathic Parkinson's Disease Trial in Worldwide (Rotigotine, Placebo)

Completed
Has Results
  • Idiopathic Parkinson's Disease
  • Rotigotine
  • Placebo
  • Birmingham, Alabama
  • +41 more
Jul 31, 2018

Idiopathic Parkinson's Disease Trial in United States (apomorphine infusion)

Unknown status
  • Idiopathic Parkinson's Disease
  • apomorphine infusion
  • Phoenix, Arizona
  • +17 more
Nov 25, 2020

Restless Legs Syndrome Trial in United States (Rotigotine)

Completed
Has Results
  • Restless Legs Syndrome
  • Rotigotine
  • Little Rock, Arkansas
  • +11 more
Mar 8, 2018

Idiopathic Parkinson's Disease Trial in China (Rotigotine, Placebo Patch, L-dopa)

Completed
Has Results
  • Idiopathic Parkinson's Disease
  • Rotigotine
  • +2 more
  • Beijing, China
  • +23 more
Mar 8, 2018

Transdermal Rotigotine User Surveillance Study

Completed
Has Results
  • Idiopathic Parkinson Disease
    • Chomutov, Czechia
    • +210 more
    Jul 11, 2018